Inovio Pharmaceuticals Inc.
INO | NASDAQ
$1.28
+$0.04 (+3.23%)
Sep 22, 2026, 1:59 PM ET · Market open
Market Data
Market Cap $85.67M
Enterprise Value $57M
Beta 1.63
Average Volume 3.45M
Shares Outstanding (Diluted) 81.62M
Shares Change YoY 110.2%
Institutional Ownership 45.39%
Exchange NASDAQ
ISIN US45773H4092
Price Performance
Price Change 1M 4.2%
Price Change 3M 9.7%
Price Change 6M -19.5%
Price Change YTD -26.6%
Price Change 1Y -50.2%
Price Change 3Y -73.5%
Price Change 5Y -98.7%
1M CAGR (ann.) 85.6%
1Y CAGR (ann.) -46.3%
5Y CAGR (ann.) -57.9%
All-Time CAGR -21.7%
Valuation
PE Ratio -1.06
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.02
PS Ratio N/A
Forward PS 1.70
PB Ratio 19.60
P/FCF Ratio -0.00
P/Adj. FCF Ratio -0.00
P/OCF Ratio -1.25
EV/Sales N/A
EV/EBIT -0.85
EV/EBITDA -0.88
EV/FCF -0.00
Earnings Yield -94.3%
FCF Yield -46314.7%
Adj. FCF Yield -48029.0%
Financial Health
Net Cash $36.67M
Total Debt $8M
Cash & Short-Term Investments $36.67M
Total Assets $49.39M
Current Ratio 1.00
Quick Ratio 1.00
Debt / Equity Ratio 1.83
Debt / EBITDA -0.12
Debt / FCF -0.00
OCF / Debt -4,958.70
Interest Coverage 0.00
Altman Z-Score -55.54
Piotroski F-Score 0
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -3.7%
Returns
Return on Assets -136.5%
Return on Equity -1005.8%
Return on Invested Capital -640.6%
Return on Capital Employed -836.6%
Return on Tangible Assets -136.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -114.7%
Revenue CAGR 5Y -54.6%
Revenue CAGR 10Y -38.1%
EPS CAGR 3Y 0.4%
EPS CAGR 5Y -49.4%
EPS CAGR 10Y -42.0%
FCF CAGR 3Y -148.8%
FCF CAGR 5Y -98.0%
FCF CAGR 10Y -53.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 41.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 9, 2026
EPS Estimate (next Q) -$0.20
EPS Growth Est (next Q) -77.0%
Revenue Est (next Q) $2.27M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $2.75
Price Target Upside 121.8%
Cash Flow
Operating Cash Flow $-39.68B
Free Cash Flow $-39.68B
Adj. Free Cash Flow $-41.15B
FCF Per Share -$0.99
OCF Per Share -$0.99
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-1.5M
Operating Income $-79.26M
EBITDA $-64.86M
Net Income $-67.43M
EPS (Diluted) -$1.17
Revenue / Employee N/A
Profit / Employee $-602.03K
Employees 112
Add to Watchlist
Select watchlists to add or remove INO